|
|
|
Volumn 6, Issue 3, 2004, Pages 212-214
|
|
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ARTICLE;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DRUG EFFECT;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
DIABETES MELLITUS;
DIABETIC ANGIOPATHIES;
HUMANS;
HYPERTENSION;
MYOCARDIAL INFARCTION;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
|
|
EID: 4644242576
PISSN: 15226417
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
